BMC Medical Recalls APAP Devices Over Firmware Defect That Can Halt Therapy
The FDA classified the action as a Class I recall after the manufacturer determined that some devices may not have received a previous firmware upgrade.
The FDA classified the action as a Class I recall after the manufacturer determined that some devices may not have received a previous firmware upgrade.
Sedgwick’s latest report shows fewer medical device recall events in Q1 2026, while sterility-related recalls drove the majority of impacted units.
The recall affects IMPRIS Neuro III-SV models that use Siemens 3T magnets, citing a risk of blocked helium venting during a magnet quench.
The FDA classified the action as a Class I recall after the manufacturer determined that some devices may not have received a previous firmware upgrade.
The initiative provides faster notifications on potentially high-risk removals or corrections for all medical devices.
Read MoreThe action addresses a discrepancy between the device’s labeled and actual performance at high flow rates, which could pose a risk of patient hypothermia.
Read MoreThe alert links purge retainer failures to potential pump stops and loss of hemodynamic support; the manufacturer is planning a service update.
Read MoreA faulty speaker wire can cause a malfunction that halts insulin delivery, prompting the US Food and Drug Administration to classify the action as a Class I recall.
Read MorePhilips Respironics is recalling certain DreamStation Auto CPAP and Auto BiPAP devices due to a programming error introduced during rework by a supplier.
Read MoreNew Sedgwick report shows Q2 2025 saw highest quarterly Class I medical device recalls in two decades, while agency launches generative AI tool for faster approvals.
Read MoreThe devices may have cracks that could lead to patient rebreathing of exhaled gases.